One patient dead, 15 others ill after reacting to injection at Lahore's Mayo Hospital
One female patient has died while fifteen others have been taken ill by reaction to an antibiotic injection at the chest ward of Mayo Hospital in Lahore. The management of the hospital reported that patients experienced a reaction to the injectable version of Ceftriaxone, a cephalosporin antibiotic.
The management of Mayo Hospital has confirmed that 15 additional patients were affected by Ceftriaxone injections, while 36-year-old Noreen died. At the moment, three patients are on ventilators.
The administration further stated that the use of the injection has been halted, and a committee has been formed under Professor Dr. Israr-ul-Haq Toor to investigate the matter. The committee includes the chief pharmacist, deputy nursing officer, AMS Mayo Hospital, and other members.
A thorough investigation would be carried out, the hospital management has said. Statements will be documented and relevant medical records will be examined. The committee will evaluate the incident's circumstances, the injection batch used, and any previous medication-related complaints. Additionally, it will ascertain if the injection was administered in accordance with normal protocols.
Professor Muhammad Haroon Hamid, the CEO of Mayo Hospital, said that individuals involved will face legal repercussions. He underlined that strict processes will be put in place to stop future occurrences of this sort.
According to reports, medications that were brought in without undergoing laboratory testing were recently acquired at Mayo Hospital. Patients received the shots without previous testing. To find possible flaws, quality assurance and purchase procedures will be reviewed.
Authorities will examine if the response resulted from a particular injectable batch, the sensitivity of the patient, or any mistakes made through the process of giving the antibiotic. The results of the investigation will dictate the next course of action. Additional safety precautions for administering medications have also been implemented by the hospital.
As the investigation continues, further updates will be provided.